Cellular Health Screening Market by Channel and Geography - Forecast and Analysis 2022-2026

The cellular health screening market share is expected to increase to USD 1.92 billion from 2021 to 2026, at a CAGR of 11.24%.

This cellular health screening market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cellular health screening market segmentation by channel (office, hospital, diagnostic labs, home, and others) and geography (North America, Europe, APAC, and Rest of World (ROW)).

What will the Cellular Health Screening Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Cellular Health Screening Market Size for the Forecast Period and Other Important Statistics

The cellular health screening market report also offers information on several market vendors, including  Bondi Health & Wellness, Cell Science Systems Ltd. Corp., Genova Diagnostics Inc., Immundiagnostik AG, Laboratory Corp. of America Holdings, Life Length SL, OPKO Health Inc., Quest Diagnostics Inc., Repeat Diagnostics Inc., SpectraCell Laboratories Inc., and Telomere Diagnostics Inc. among others.

Cellular Health Screening Market: Key Drivers, Trends, and Challenges

The rising applications of cellular health screening in personalized medicine is notably driving the cellular health screening market growth, although factors such as lack of trained laboratory technicians may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cellular health screening industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Cellular Health Screening Market Driver

One of the key factors driving the global industrial market growth is the rising applications of cellular health screening in personalized medicine. A significant number of people in the US who seek medical care undergo medical misdiagnose, and the factors causing this can be delayed and lead to inaccurate diagnosis. It has been indicated that misdiagnosis has directly harmed the patients, resulting in permanent disability or death. It is estimated that approximately 30%-32% of the annual healthcare spending was on unnecessary or incorrect diagnoses in the US. Thus, in this scenario, personalized medicine results in increasing the quality of clinical practice due to its targeted care pathways and reducing the overall cost of healthcare. As a result, there is growing popularity of cellular health screening in the development of personalized medicines for the early detection and accurate treatment methods, which, in turn, will drive the market growth during the forecast period.

Key Cellular Health Screening Market Trend

Increased prevalence of cancer is one of the key industrial market trends that is expected to impact the industry positively in the forecast period. According to the International Agency for Research on Cancer (IARC), 20% of people develop cancer during their lifetime globally, and 12.5% of men and 9.09% of women die from the disease. On December 14, 2020, the IARC released updated the Globocan 2020 report, which estimated that the global cancer cases rose to 19.3 million in 2020, along with 10 million associated deaths. Moreover, the US National Cancer Institute estimates that by 2030, the global number of cancer cases and deaths are expected to be 21.6 million and 13.5 million, respectively. Cellular health screening is one of the popular methods for detecting different cancer types. Such factors will prompt the vendors to further develop associated advanced and upgraded versions of products, which will support market growth in the coming years.

Key Cellular Health Screening Market Challenge

One of the key challenges to the global industrial market growth is the lack of trained laboratory technicians. Most medical professionals lack knowledge about the technology, its benefits, and the handling of patients during point-of-care (POC) testing. Several medical personnel is unfamiliar with routine laboratory procedures such as proper patient preparation, sample collection, calibration, instrument maintenance, and quality control. In the countries of Africa and in developing countries such as China, India, and Brazil, the lack of technical expertise in POC diagnosis delays the availability of test results, which, in turn, interrupts the treatment outcome. Many medical professionals are unable to interpret the basic test results during the test or identify the abnormalities under the microscope. This lack of expertise enhances the probability of a wrong diagnosis, which may limit the market growth during the forecast period.

This cellular health screening market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Cellular Health Screening Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

•  Bondi Health & Wellness
• Cell Science Systems Ltd. Corp.
• Genova Diagnostics Inc.
• Immundiagnostik AG
• Laboratory Corp. of America Holdings
• Life Length SL
• OPKO Health Inc.
• Quest Diagnostics Inc.
• Repeat Diagnostics Inc.
• SpectraCell Laboratories Inc.
• Telomere Diagnostics Inc.

 

This statistical study of the cellular health screening market encompasses successful business strategies deployed by the key vendors. The cellular health screening market is fragmented and the vendors are deploying growth strategies such as the expansion of distribution channels to compete in the market.

Product Insights and News

• Bondi Health Wellness - The company offers products such as cellular health tests.  
• Bondi Health Wellness - Through the unified segment, the company offers services for detox, gut health, fatigue recovery, weight loss, fertility, autoimmune conditions, wellness, hormonal health, children's health, anxiety, depression, sports performance, and reiki. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The cellular health screening market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Parent Market Analysis

Technavio categorizes the Global cellular health screening market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cellular health screening market during the forecast period.

Which are the Key Regions for Cellular Health Screening Market?

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market's growth will originate from North America during the forecast period. The US is the key market for cellular health screening in North America. Market growth in this region will be faster than the growth of the market in Europe and Rest of World (ROW).

The rise in insurance coverage, increase in R and D expenditure, rise in geriatric population with chronic diseases, high healthcare spending, and increase in promotions about the use of point-of-care (POC) tests for the early detection of diseases will facilitate the cellular health screening market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In early 2020, the outbreak of COVID-19 led to a halt in the general operations of healthcare facilities and treatment centers in the region as they became more focused on treating COVID-19 patients, which restricted the number of cellular health screening and emergency department visits, which, in turn, negatively impacted the growth of the cellular health screening market in the region. For instance, according to CDC, emergency department visits in the US declined 42% during the early part of the COVID-19 pandemic, from 2.1 million per week to 1.2 million. However, by January 2021, lockdown restrictions in various countries were relaxed, which helped in the resumption of business activities. The resumption of various preclinical studies and pharmaceutical operations in the region will drive the demand for cellular health screening in North America during the forecast period.

What are the Revenue-generating Channel Segments in the Cellular Health Screening Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The cellular health screening market share growth by the office segment will be significant during the forecast period. Though many cellular health screening tests are offered directly to the patients, some companies still prefer delivering their services by a physician to ensure patient safety and the accuracy of the sample collection process. Such factors will drive the growth of the global cellular health screening market through the office segment in the coming years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the cellular health screening market size and actionable market insights on post COVID-19 impact on each segment.

Cellular Health Screening Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the cellular health screening market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Cellular Health Screening Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Decelerate at a CAGR of 11.24%
Market growth 2022-2026	$ 1.92 billion
Market structure	Fragmented
YoY growth (%)	14.89
Regional analysis	North America, Europe, APAC, and Rest of World (ROW)
Performing market contribution	North America at 40%
Key consumer countries	US, China, India, Germany, and UK
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Bondi Health & Wellness, Cell Science Systems Ltd. Corp., Genova Diagnostics Inc., Immundiagnostik AG, Laboratory Corp. of America Holdings, Life Length SL, OPKO Health Inc., Quest Diagnostics Inc., Repeat Diagnostics Inc., SpectraCell Laboratories Inc., and Telomere Diagnostics Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Cellular Health Screening Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive cellular health screening market growth during the next five years
• Precise estimation of the cellular health screening market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the cellular health screening industry across North America, Europe, APAC, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of cellular health screening market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch